Clinical Trials
2 trialsNCT05481437 2026-04-13
A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
Takeda
Recruiting
NCT03440788 2019-10-28
Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin's Lymphoma Receiving Brentuximab Vedotin
Multinational Center for Quality of Life Research, Russia
Unknown